Nicholas Hoffman & Company, Llc. Amgen Inc Transaction History

Nicholas Hoffman & Company, Llc.

$2.48 Billion
Q4 2024

A detailed history of Nicholas Hoffman & Company, Llc. transactions in Amgen Inc stock. As of the latest transaction made, Nicholas Hoffman & Company, Llc. holds 1,173 shares of AMGN stock, worth $341,530. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,173

Previous 1,033 13.55%

Holding current value

$341,530

Previous $332,000 8.13%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$258.78 - $328.31 $36,229 - $45,963	140 Added 13.55%	1,173 $305,000
Q3 2024 Oct 25, 2024	BUY	$309.38 - $337.38 $60,329 - $65,789	195 Added 23.27%	1,033 $332,000
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $28,114 - $34,166	-107 Reduced 11.32%	838 $261,000
Q1 2024 Apr 22, 2024	BUY	$268.87 - $324.56 $806 - $973	3 Added 0.32%	945 $268,000
Q4 2023 Jan 31, 2024	BUY	$255.7 - $288.46 $511 - $576	2 Added 0.21%	942 $271,000
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $5,028 - $6,243	23 Added 2.51%	940 $252,000
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $642 - $760	3 Added 0.33%	917 $203,000
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $19,417 - $23,667	86 Added 10.39%	914 $220,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $189,636 - $240,956	828 New	828 $217,000
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $190,335 - $211,810	825 New	825 $201,000
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $188,737 - $215,992	-949 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$212.27 - $248.7 $212 - $248	1 Added 0.11%	949 $202,000
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $27,562 - $30,578	118 Added 14.22%	948 $231,000
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $184,185 - $214,638	830 New	830 $207,000
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $265,461 - $325,757	-1,342 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $24,237 - $32,146	133 Added 11.0%	1,342 $272,000
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $189 - $243	1 Added 0.08%	1,209 $292,000
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $174 - $208	1 Added 0.08%	1,208 $234,000
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $9,668 - $11,333	58 Added 5.05%	1,207 $222,000
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $207,819 - $234,258	1,149 New	1,149 $218,000

Others Institutions Holding AMGN

# of Institutions

3,144

Shares Held

415M

Call Options Held

8.2M

Put Options Held

6.65M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Hoffman & Company, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Hoffman & Company, Llc. with notifications on news.

Account

Nicholas Hoffman & Company, Llc. Amgen Inc Transaction History